Physician

Andrew Victores, M.D.

According to 2025 Medicare claims, Andrew Victores, M.D. (NPI: 1609135466) practices otolaryngology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is SOUTHEAST TEXAS EAR, NOSE & THROAT, LLP (NPI: 1962477406; TIN: 760454034) and primary practice location at 77701-4666.

Victores' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 422 traditional Medicare patients, billed 3,294 HCPCS/CPT codes, and received $223,850 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 917 prescription claims across 300 beneficiaries totaling $39,111 in drug costs, led by Ipratropium Bromide (Ipratropium Bromide). 2023 DME data shows 11 claims. Open Payments data shows 13 records totaling $367. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,559 to $223,850. Similarly, Part D prescription costs have risen steadily, from $3,916 to $39,111. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	47	80	$5,559
2018	169	945	$43,176
2019	329	1,932	$184,227
2020	525	2,938	$191,087
2021	589	3,484	$271,657
2022	825	5,466	$435,870
2023	866	5,617	$355,758
2024	422	3,294	$223,850

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	34	68	$3,916
2018	66	206	$14,828
2019	157	357	$9,932
2020	173	485	$16,041
2021	246	723	$20,333
2022	257	701	$17,763
2023	253	766	$21,965
2024	300	917	$39,111

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$5,846
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	69	127	$111
70486	Ct scan of face without contrast	103	107	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	75	81	$72
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	81	81	$54
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	271	454	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ipratropium Bromide	Ipratropium Bromide	295	8,444	$8,961
Omeprazole	Omeprazole	123	4,933	$1,224
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	11	118	$1,151
Fluticasone Propionate	Fluticasone Propionate	73	4,200	$796
Methylprednisolone	Methylprednisolone	71	426	$473

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$367	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Victores, M.D.?

Tedicare shows public-source Medicare data for Andrew Victores, M.D. (NPI 1609135466), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Victores, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Victores, M.D.?

Andrew Victores, M.D. is linked to SOUTHEAST TEXAS EAR, NOSE & THROAT, LLP (billing NPI 1962477406) in the available physician profile data.

Does Andrew Victores, M.D. have Open Payments data?

Andrew Victores, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.